Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics
Margarita Udall, Maria L. Rizzo, Juliet Kenny, et al.
Diagnostic Pathology (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging
Shanshan He, Ruchir Bhatt, Carl Brown, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 12, pp. 1794-1806
Closed Access | Times Cited: 402
Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy
Yuting Liu, Jon Zugazagoitia, Fahad Shabbir Ahmed, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 4, pp. 970-977
Open Access | Times Cited: 263
An adoption-implementation framework of digital green knowledge to improve the performance of digital green innovation practices for industry 5.0
Shi Yin, Yuanyuan Yu
Journal of Cleaner Production (2022) Vol. 363, pp. 132608-132608
Closed Access | Times Cited: 254
Translational AI and Deep Learning in Diagnostic Pathology
Ahmed Serag, Adrian Ion‐Mărgineanu, Hammad Qureshi, et al.
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 219
Checkpoint inhibitor immunotherapy in kidney cancer
Wenxin Xu, Michael B. Atkins, David F. McDermott
Nature Reviews Urology (2020) Vol. 17, Iss. 3, pp. 137-150
Closed Access | Times Cited: 217
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Sanjeevani Arora, R. A. Velichinskii, Randy W. Lesh, et al.
Advances in Therapy (2019) Vol. 36, Iss. 10, pp. 2638-2678
Open Access | Times Cited: 172
Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression‐based study
Yongfu Xiong, Kang Wang, He Zhou, et al.
Cancer Medicine (2018) Vol. 7, Iss. 9, pp. 4496-4508
Open Access | Times Cited: 169
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
Emina Torlakovic, Hyun J. Lim, Julien Adam, et al.
Modern Pathology (2019) Vol. 33, Iss. 1, pp. 4-17
Open Access | Times Cited: 160
Microsatellite instability in Gastric Cancer: Between lights and shadows
Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, et al.
Cancer Treatment Reviews (2021) Vol. 95, pp. 102175-102175
Open Access | Times Cited: 154
Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer
Nicola Gaynor, John Crown, Denis M. Collins
Seminars in Cancer Biology (2020) Vol. 79, pp. 44-57
Open Access | Times Cited: 143
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Rangarirai Makuku, Neda Khalili, Sepideh Razi, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 104
Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers
Lucile Vanhersecke, Antoine Bougoüin, Amandine Crombé, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 5, pp. 100063-100063
Closed Access | Times Cited: 48
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 38
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
Harry Ho Man Ng, Ren Yuan Lee, Siting Goh, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000987-e000987
Open Access | Times Cited: 100
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
Zuzana Macek Jílková, Caroline Aspord, Thomas Decaens
Cancers (2019) Vol. 11, Iss. 10, pp. 1554-1554
Open Access | Times Cited: 93
Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies
Ansh Kapil, Armin Meier, Aleksandra Żuraw, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 90
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M. Conroy, Sarabjot Pabla, Mary Nesline, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 83
Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application
Zhen Zhao, Jia Fan, Yen‐Michael S. Hsu, et al.
Lab on a Chip (2019) Vol. 19, Iss. 7, pp. 1114-1140
Open Access | Times Cited: 82
PD-L1 expression by Tumor Proportion Score (TPS) and Combined Positive Score (CPS) are similar in non-small cell lung cancer (NSCLC)
Pedro De Marchi, Letícia Ferro Leal, Vinícius Duval da Silva, et al.
Journal of Clinical Pathology (2021) Vol. 74, Iss. 11, pp. 735-740
Closed Access | Times Cited: 82
PD−L1 immunostaining: what pathologists need to know
Mohammed Akhtar, Sameera Rashid, Issam Al‐Bozom
Diagnostic Pathology (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 71
High-plex Multiomic Analysis in FFPE at Subcellular Level by Spatial Molecular Imaging
Shanshan He, Ruchir Bhatt, Carl Brown, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 62
PD-L1 testing by immunohistochemistry in Immuno-Oncology
Semir Vranić, Zoran Gatalica
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 61
Deep Learning for Lung Cancer Diagnosis, Prognosis and Prediction Using Histological and Cytological Images: A Systematic Review
Athena S. Davri, Effrosyni Birbas, Theofilos Kanavos, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3981-3981
Open Access | Times Cited: 30
Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring
Chunyan Liu, Fang Fang, Ying Kong, et al.
Diagnostic Pathology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Product review: avelumab, an anti-PD-L1 antibody
Julie Collins, James L. Gulley
Human Vaccines & Immunotherapeutics (2018) Vol. 15, Iss. 4, pp. 891-908
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top